umu.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes.
Umeå universitet, Medicinsk fakultet, Folkhälsa och klinisk medicin, Medicin. Medicin.
Umeå universitet, Medicinsk fakultet, Folkhälsa och klinisk medicin, Medicin. Medicin.
Umeå universitet, Medicinsk fakultet, Folkhälsa och klinisk medicin, Medicin. Medicin.
Umeå universitet, Medicinsk fakultet, Folkhälsa och klinisk medicin, Medicin. Medicin.
2007 (engelsk)Inngår i: Metabolism: Clinical and Experimental, ISSN 0026-0495, E-ISSN 1532-8600, Vol. 56, nr 2, s. 190-198Artikkel i tidsskrift (Fagfellevurdert) Published
sted, utgiver, år, opplag, sider
2007. Vol. 56, nr 2, s. 190-198
Emneord [en]
Adipocytes/drug effects/*metabolism, Adult, Aged, Blotting; Western, Cells; Cultured, Female, Glucose/metabolism/*pharmacology, Glucose Transporter Type 4/metabolism, Humans, Hypoglycemic Agents/*pharmacology, Indicators and Reagents, Insulin/*pharmacology, Insulin Resistance/*physiology, Intracellular Signaling Peptides and Proteins/metabolism, Male, Middle Aged, Phosphoproteins/*metabolism, Signal Transduction/drug effects
Identifikatorer
URN: urn:nbn:se:umu:diva-18201DOI: doi:10.1016/j.metabol.2006.09.012<PubMedID: 17224332OAI: oai:DiVA.org:umu-18201DiVA, id: diva2:157874
Tilgjengelig fra: 2007-11-29 Laget: 2007-11-29 Sist oppdatert: 2018-06-09bibliografisk kontrollert
Inngår i avhandling
1. Fat cell insulin resistance: an experimental study focusing on molecular mechanisms in type 2 diabetes
Åpne denne publikasjonen i ny fane eller vindu >>Fat cell insulin resistance: an experimental study focusing on molecular mechanisms in type 2 diabetes
2007 (engelsk)Doktoravhandling, med artikler (Annet vitenskapelig)
Abstract [en]

The aim of the present thesis was to further increase our understanding of mechanisms contributing to and maintaining cellular insulin resistance in type 2 diabetes (T2D). For this reason, the effects of high glucose and insulin levels on glucose transport capacity and insulin signaling, with emphasis on insulin receptor substrate 1 (IRS-1) were assessed in fat cells. Altered levels of IRS-1 have previously been observed in adipose tissue from insulin-resistant and T2D subjects.

A high glucose level (≥15 mM) for 24 h exerted only a minor impairment on glucose transport capacity in human adipocytes, as opposed to rat adipocytes. However, when combined with a high insulin level (104 µU/ml), basal and insulin-stimulated glucose transport was significantly impaired in both human and rat adipocytes. This was associated with a depletion of IRS-1 and IRS-2 protein levels in rat adipocytes, as a result of post-translational changes and altered gene transcription, respectively. In human adipocytes was only IRS-1 protein levels reduced. The high glucose/high insulin setting achieved maximal impairment of glucose transport within 6 h. Subsequent incubations of rat adipocytes under physiological conditions could partially restore insulin sensitivity. Interestingly, in both human and rat fat cells, decreased levels of IRSs occurred after the establishment of impaired glucose transport, suggesting that the observed depletion of IRSs is a consequence rather than a cause of insulin resistance. Nonetheless, IRS depletion is likely to further aggravate insulin resistance.

Tyrosine phosphorylation of IRS-1 upon insulin stimulation activates the signaling pathway that mediates glucose transport. Pre-treatment of human adipocytes with high glucose and insulin levels was not associated with any alterations in the total IRS-1 Tyr612 phosphorylation following 10 min insulin stimulation. However, a significant increase in basal Tyr612 phosphorylation was observed. Furthermore, a rise in basal IRS-1 Ser312 phosphorylation was found. This is associated with reduced IRS-1 function and is considered to target IRS-1 to degradation pathways, and thus could potentially explain the observed decrease in IRS-1 protein levels. Our results imply an enhanced activation of insulin’s negative-feedback control mechanism that inhibit IRS-1 function. This could potentially have contributed to the observed impairment of insulin action on glucose transport in these cells. Accordingly, we have also shown that the downstream activation of protein kinase B upon insulin-stimulation is significantly impaired in human adipocytes exposed to the high glucose/high insulin setting, indicating a defect in the signaling pathway mediating glucose transport.

We also investigated whether there are humoral factors in the circulation of T2D patients that contribute to peripheral insulin resistance. Human adipocytes cultured for 24 h in medium supplemented with 25% serum from T2D subjects, as compared to serum from non-diabetic subjects, displayed significantly reduced insulin-stimulated glucose uptake capacity. The effect could neither be attributed to glucose, insulin, FFA, TNF-α or IL-6 levels in the serum, but other circulating factor(s) seem to be of importance.

In conclusion, chronic conditions of elevated glucose and/or insulin levels all impair insulin action on glucose turnover, but to different extents. A clear distinction between rat and human fat cells in the response to these different milieus was also observed. Alterations in the function of the key insulin signaling protein IRS-1 might be involved in the mechanisms underlying the impaired glucose uptake capacity. IRS-1 reduction however, occurs after but probably aggravates the existing insulin resistance. The effects of high glucose and/or insulin levels may be of importance in T2D, but additional novel factors present in the circulation of T2D patients seem to contribute to cellular insulin resistance.

sted, utgiver, år, opplag, sider
Umeå: Folkhälsa och klinisk medicin, 2007. s. 60
Serie
Umeå University medical dissertations, ISSN 0346-6612 ; 1088
Emneord
adipocyte, insulin signaling, insulin, glucose, IRS-1, glucose uptake, insulin resistance, typ 2 diabetes, serum
HSV kategori
Identifikatorer
urn:nbn:se:umu:diva-1078 (URN)978-91-7264-268-3 (ISBN)
Disputas
2007-04-27, Betula, 6M, Norrlands Universitetssjukhus, Umeå, 09:00 (engelsk)
Opponent
Veileder
Tilgjengelig fra: 2007-04-05 Laget: 2007-04-05 Sist oppdatert: 2018-06-09bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=17224332&dopt=Citation

Personposter BETA

Buren, JonasSvensson, MariaEriksson, Jan

Søk i DiVA

Av forfatter/redaktør
Buren, JonasSvensson, MariaEriksson, Jan
Av organisasjonen
I samme tidsskrift
Metabolism: Clinical and Experimental

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 282 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf